Tactile Systems Technology Inc

TCMD

$13.15

Closing

▼-0.75%

1D

▼-8.04%

YTD

TCMD

BBG001THH5G1

Market cap

$315.64M

52 week high

$18.04

52 week low

$9.70

Volume

31,980

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$315.64M

Analysts' Rating

STRONG BUY

Price Target (Mean)

20.33

Total Analysts

4

P/E

9.63

Operating Margin

7.99%

Beta

1.17

Revenue Growth

7.14%

52 week high

$18.04

52 week low

$9.70

Div. Yield

%

EPS Growth

-300.00

Company Profile

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company’s areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company’s Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.